The NDP-backed pharmacare plan is a corporate handout as written
The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
Liberals’ fall priorities should centre on building support from NDP, key voting blocs: lobbyists, pollsters
With a current ‘hodgepodge’ of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav Baran.
Patients know about pharmacare: let’s listen to them on Bill C-64
Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
Health care is more than treatment—it’s time to get serious about disease prevention
The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic illness. National pharmacare offers a dream—perhaps unrealistically, given the cost—that one day Canada might have a universal program covering all drugs for all diseases. Yet despite this hope, the proposed framework […]
Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert
Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and indirectly in terms of improvements in health care, says Steve Morgan, a professor of health policy at the University of British Columbia.
Patient involvement in pharmacare is critical to its success
Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.
Time for Poilievre to join a constructive pharmacare conversation
Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre Poilievre’s turn.
Equity must be the priority for national pharmacare
Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
Pharmacare pivotal to ensure vital medications for all Canadians: CML Society of Canada
Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the Pharmacare Act as a pivotal measure to ensure universal access to vital medications for all Canadians. Its multi-faceted approach—including collaboration, policy development, and strategic initiatives such as national pharmacare and bulk […]
A national pharmacare plan should cover what’s best for patients, not what’s new
Using insulin is always challenging, so access to a broad range of appropriate options is vital.
